|
Depuy synthes is submitting this report pursuant to the provisions of 21 cfr, part 803.This report may be based on information which depuy synthes has not been able to investigate or verify prior to the required reporting date.This report does not reflect a conclusion by fda, depuy synthes or its employees that the report constitutes an admission that the device, depuy synthes, or its employees caused or contributed to the potential event described in this report.If the information is unknown, not available or does not apply, the section/field of the form is left blank.H10 additional narrative: d9: complainant part is not expected to be returned for manufacturer review/investigation.E3: initial reporter is a synthes employee.H3, h4, h6: without a lot number the device history records review could not be completed.Product was not returned.Based on the information available, it has been determined that no corrective and/or preventative action is proposed.This complaint will be accounted for and monitored via post market surveillance activities.If additional information is made available, the investigation will be updated as applicable.Device was used for treatment, not diagnosis.If information is obtained that was not available for the initial medwatch, a follow-up medwatch will be filed as appropriate.
|
|
Device report from japan reports an event as follows: it was reported that on (b)(6) 2023, the patient underwent orif surgery for femoral trochanteric fracture with dhs/dcs impactor.During surgery, the dhs/dcs impactor in question was used to insert the tube plate barrel part into the body, and when it was struck with a hammer, the tip of the dhs/dcs impactor broke after being struck several times.The surgery was continued using an in-hospital substitute and was completed without any problems.The surgery was completed successfully without any surgical delay.No further information is available.This report is for a dhs®/dcs® impactor.This is report 1 of 1 for (b)(4).
|